TuisRMTI • NASDAQ
add
Rockwell Medical Inc
Vorige sluiting
$1,15
Dagwisseling
$1,12 - $1,18
Jaarwisseling
$0,78 - $2,12
Markkapitalisasie
44,53 m USD
Gemiddelde volume
1,14 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 15,93 m | -43,75% |
Bedryfskoste | 3,86 m | -10,39% |
Netto inkomste | -1,75 m | -205,35% |
Netto winsgrens | -11,01 | -287,24% |
Wins per aandeel | — | — |
EBITDA | -1,04 m | -141,95% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 23,71 m | 29,74% |
Totale bates | 57,49 m | 0,70% |
Totale aanspreeklikheid | 20,47 m | -26,77% |
Totale ekwiteit | 37,02 m | — |
Uitstaande aandele | 39,41 m | — |
Prys om te bespreek | 1,22 | — |
Opbrengs op bates | -7,19% | — |
Opbrengs op kapitaal | -8,38% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -1,75 m | -205,35% |
Kontant van bedrywe | -1,31 m | -130,57% |
Kontant van beleggings | -4,31 m | 29,50% |
Kontant van finansiering | 6,74 m | 191,57% |
Netto kontantverandering | 1,13 m | 137,47% |
Beskikbare kontantvloei | -1,72 m | -155,34% |
Meer oor
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease and chronic kidney disease.
The company's primary customers are dialysis providers. Wikipedia
Gestig
1996
Hoofkwartier
Webwerf
Werknemers
244
